Generic Pharmaceutical Business Investment Opportunities

Established over 30 years ago, the business specializes in the manufacturing of generic pharmaceuticals, focusing on ophthalmic sterile preparations and healthcare products. - Located in Dhanu Rd, Thane, the company operates with a small but dedicated team of employees committed to quality and innovation. - The product line includes over 100 items, featuring eye and ear drops, nasal sprays, tablets, capsules, and syrups designed for various health and wellness applications. - The company holds expertise in producing ophthalmic sterile preparations, which are essential for ensuring safety and effectiveness in eye and ear treatments. - Products are marketed under the company’s own brand name, enhancing brand recognition in the pharmaceutical industry. - The business generates revenue through direct sales to pharmacies, hospitals, and healthcare providers, providing essential health solutions for consumers. - Business has a manufacturing license and registration certificate.

Operates as a pharmaceutical manufacturing company in Ahmedabad producing cardiac-diabetic, psychotropic, neuro, and antibiotic medicines. - Serves 300+ clients across India through a cash-based business model supported by 25+ years of promoter experience. - Manufactures products under its own brand and also undertakes contract manufacturing for 12–15 companies. - Generates around 80% of revenue from its branded medicines and the remaining 20% from contract manufacturing. - Supplies products to 150+ multi-specialty hospitals across Gujarat and Maharashtra and fulfills government tenders in both states. - Drop in sales as the owner was busy, and was not able to dedicate enough time to the business. - Holds GMP, GLP, GDP, and ISO certifications along with valid GST registration and a manufacturing license.

Operates a pharmaceutical manufacturing unit in Nalagarh, Baddi with WHO-GMP, GLP and ISO certifications. - Produces tablets, capsules, liquid orals, ointments and a CEFA dry powder injection line for government supply, domestic buyers and export clients. - Facility is designed as a general section layout with controlled environments for multiple dosage forms. - Current handling capacity is around 1000 cartons across product categories. - Holds Food and Drug licenses along with active registration on the MCA portal. - Positioned to serve institutional orders and private-label requirements with compliant processes and quality documentation. - Experienced team manages regulatory, technical and quality operations with a focus on international standards. - The business faced legal issues five years ago related to the manufacturing of COVID vaccines. Since then, the charges have been dropped, and it is now legally clear to operate.

Operates a pharmaceutical manufacturing unit in Nalagarh, Baddi with WHO-GMP, GLP and ISO certifications. - Produces tablets, capsules, liquid orals, ointments and a CEFA dry powder injection line for government supply, domestic buyers and export clients. - Facility is designed as a general section layout with controlled environments for multiple dosage forms. - Current handling capacity is around 1000 cartons across product categories. - Holds Food and Drug licenses along with active registration on the MCA portal. - Positioned to serve institutional orders and private-label requirements with compliant processes and quality documentation. - Experienced team manages regulatory, technical and quality operations with a focus on international standards. - The business faced legal issues five years ago related to the manufacturing of COVID vaccines. Since then, the charges have been dropped, and it is now legally clear to operate.

The company is engaged in the business of haemostatic medicines, contraceptives, and calcium tablets. - We do not manufacture the products ourselves and rely on a third-party manufacturer. - Our business operates on a B2B model, selling products to stockists. - Currently, we have 19 stockist clients. - Revenue is generated primarily through bulk sales. - The company is a private limited entity with GST and MSME registration. - We are not USFDA approved.

The company is in a pre-revenue phase and will engage in pharmaceutical manufacturing and packaging. - We will establish a transformative generic medicine facility with rapid-changeover capabilities and low capital requirements. - Operations will focus on emerging and frontier markets, especially high-growth regions like Africa. - We will import exclusively from the USA, Canada, and Europe. - All manufacturing will meet local, FDA, and EU cGMP standards to obtain WHO certification. - Once the investment is secured, we will register the company and begin operations.

Business is located in Bhubaneswar, specializing in the development of drugs that induce endogenous nitric oxide in humans and animals. - Company is incubated in a well-known biotechnological institute in Bhubaneswar, Orissa. - Company has successfully completed the research to identify the chemical structure of the drug that can induce nitric oxide production and is now seeking funding to proceed with development. - Research findings are patented and protected in India, USA, and EU, providing the company with a competitive advantage in the market. - The company is ready to commence the development phase upon securing the necessary funding, presenting an opportunity for potential investors to participate in an innovative and potentially lucrative venture in the pharmaceutical and nutraceutical industry. - Promoter is a medical researcher and has 50 years of experience. - The company is registered with the Ministry of Corporate Affairs (MCA), ensuring compliance with regulatory and legal requirements.

The business operates in the pharmaceutical and medical devices export industry, focusing on therapies such as anaemia management, nephrology, and gynaecology. - With a current staff of 6 permanent employees, the business has made significant strides in increasing its client base, growing from 2 clients in the last fiscal year to 15 clients in the current fiscal year. - The company has outlined a road-map to achieve a turnover of 100 crore in the next 2 fiscal years, indicating a strong growth trajectory. - Initially starting as a short-term trading model, the business is now transitioning towards brand building and is in the process of registering its brand in 4 countries, showcasing a strategic shift in its business model. - The product portfolio comprises 80% medicines and 20% medical devices, with a focus on exporting these products to countries such as Zambia, Uganda, and Kenya. - The business sources medicines and equipment from India and exports them to international markets, highlighting its role in facilitating the global distribution of pharmaceutical and medical devices. - With a valid GST certificate for operations, the business is compliant with regulatory requirements, adding a layer of credibility to its operations.

Business owner of a drug wholesale business planning to establish a pharmaceutical drug manufacturing plant. - The focus will be on creating a portfolio of drugs under the company's own brand name. - Initially, the manufacturing will concentrate on oral tablets and capsules, with future plans for expansion into other drug categories. - The company aims to supply its products to distributors across West Bengal, Jharkhand, Bihar, and Odisha. - Raw materials for the manufacturing process will be sourced from Ahmedabad and Visakhapatnam. - Will be obtaining drug license and FDA approval once the business launches.